# Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting
Canonical URL: https://biopharmsignal.com/news/ADPT/adaptive-biotechnologies-showcases-leadership-in-hematology-oncology-mrd-with-new-clonoseqr-data-driving-treatment-interventions-at-2025-ash-annual-meeting
Ticker: ADPT
Company: Adaptive Biotechnologies
Source: Adaptive Biotechnologies
Published: 2025-12-06 13:30 EST
Original Source URL: https://investors.adaptivebiotech.com
## Summary

SEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, announced growing interventional use of

## Article Body
SEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, announced growing interventional use of
## Recent Company News
- 2026-05-29 11:30 EST — [At ASCO and EHA 2026, New Data Reinforce the Pivotal Role of clonoSEQ® MRD Testing Across Hematology Clinical Practice and Research](https://biopharmsignal.com/news/ADPT/at-asco-and-eha-2026-new-data-reinforce-the-pivotal-role-of-clonoseqr-mrd-testing-across-hematology-clinical-practice-and-research) — Source: Adaptive Biotechnologies
- 2026-05-05 20:05 EST — [Adaptive Biotechnologies Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/ADPT/adaptive-biotechnologies-reports-first-quarter-2026-financial-results) — Source: Adaptive Biotechnologies
- 2026-04-15 20:05 EST — [Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026](https://biopharmsignal.com/news/ADPT/adaptive-biotechnologies-to-report-first-quarter-2026-financial-results-on-may-5-2026) — Source: Adaptive Biotechnologies
- 2026-02-05 21:05 EST — [Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results](https://biopharmsignal.com/news/ADPT/adaptive-biotechnologies-reports-fourth-quarter-and-full-year-2025-financial-results) — Source: Adaptive Biotechnologies
- 2026-01-27 21:05 EST — [Adaptive Biotechnologies to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/ADPT/adaptive-biotechnologies-to-participate-in-upcoming-investor-conferences) — Source: Adaptive Biotechnologies
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)